The adrenogenital syndrome is a rare genetic disorder in which there is a failure of one of the enzymes involved in the production of corticosteroids by the adrenal cortex. The condition is an autosomal recessive. Buphthalmos is an uncommon ocular condition, and it would be surprising if buphthalmos and the adrenogenital syndrome were to coexist in the same patient. This paper describes two such patients.
The patient presented with collapse and failure to thrive one week after birth, and was treated with 9-oa-fluorocortisone, DOCA, and dexamethasone. On April 4 a moon-faced appearance was noted. A clinical note of prominent eyes was made on June 2. On August 7 he was referred to the Eye Department with an irritable right eye.
Examination
He was examined on August I3 under Pentothal and nitrous oxide anaesthesia, with scoline as muscle relaxant, and positive pressure ventilation. The right eye was described as having buphthalmos, with corneal oedema, deep anterior chamber, and an intraocular pressure of 66 mm. Hg (Schiotz). The corneal diameters were not measured. At 7 days he failed to feed, looked lethargic, and began to lose weight. The serum electrolytes showed potassium 9-8 mEq/litre and sodium 125 mEq/litre. The genitalia were normal. He was treated with hydrocortisone, cortisone, and dexamethasone. The serum potassium fell from 9-8 to 4-8 mEq/litre, and the serum sodium rose from I28 to 134 mEq/litre. The ketosteroid excretion fell from 5 to I-4 mg./24 hrs, and the I 7-hydroxycorticosteroids from 2-9 to o -8 mg./24 hrs. He was sent home at 2 months of age on dexamethasone o 5 mg. daily, 9-x-fluorohydrocortisone 0s05 mg. 
Discussion
Buphthalmos may be associated with local ocular abnormalities, such as persistent primary hyperplastic vitreous, Axenfeld's anomaly, and aniridia; alternatively, buphthalmos may be associated with the phakomatoses, such as the Sturge-Weber syndrome, or neurofibromatosis. The only common metabolic disorder associated with buphthalmos is Lowe's syndrome of buphthalmos, amino aciduria, and mental deficiency. It is interesting to note that the second patient showed a generalized slight amino aciduria. Franceschetti (i 962), however, found amino aciduria in 46 4 per cent. of 63 cases of buphthalmos. The association of buphthalmos with adrenogenital syndrome does not appear to have been described previously.
The incidence of buphthalmos was stated by Duke-Elder (I969) to be between O0oi-o0o4 per cent. of ophthalmic patients. On the other hand Childs, Grumbach, and Van Wyk (I956) found the incidence of adrenogenital syndrome to be I in 67,000 live births in the State of Maryland, U.S.A. Buphthalmos and adrenogenital syndrome are therefore rare conditions unlikely to co-exist by chance in the same patient, but as they have been found in two patients in the same area the occurrence is unlikely to be fortuitous. That the association appears not to have been described earlier is due to the fact that, until the advent of systemic steroids and modern biochemistry, patients with congenital adrenogenital syndrome died shortly after birth, before the onset of buphthalmos could be observed.
Two possibilities occur: that the relationship between buphthalmos and adrenogenital syndrome is genetic, or that the occurrence of buphthalmos in cases of adrenogenital syndrome is due to treatment with systemic steroids.
The latter theory, that the buphthalmos is due to the administration of systemic steroids, is at first sight attractive. However, most authors agree that the rise in intraocular pressure is much less marked after treatment with systemic steroids than after the use of local steroids. Williamson, Paterson, McGavin, Jasani, Boyle, and Doig (I969) examined I48 patients with rheumatoid arthritis who were treated with systemic steroids and found only one case of steroid glaucoma. Bernstein and Schwartz (I962) , after examining 48 patients receiving long-term steroid therapy, concluded that there was a small but statistically significant increase in intraocular pressure. Buphthalmos does not appear to have been described earlier with systemic steroid treatment, but Hofmann and Hauser (I964) described a case of juvenile glaucoma in a i o-year-old boy who was given systemic steroids for lupus erythematosus. Duke-Elder (i 969) goes so far as to suggest that, if glaucoma occurs with local steroid therapy, systemic therapy may be substituted for local therapy.
It seems, therefore, that there is probably a genetic relationship between buphthalmos and adrenogenital syndrome, especially as the former, like the latter, is frequently inherited by means of a recessive gene. Patients with adrenogenital syndrome do not show other genetically related defects, apart from abnormalities of the urogenital tract.
From a practical point of view it is of little consequence whether the buphthalmos is due to steroid overdosage or to a genetic abnormality; in both cases the dose of steroid given should be as low as is compatible with the child's health and vitality. All who have the responsibility for looking after cases of adrenogenital syndrome should be aware of buphthalmos as a possible complication.
Summary
Two instances of buphthalmos occurring in cases of adrenogenital syndrome are described. It is suggested that these conditions are associated, and that the association is probably genetic.
